← All organizations
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2011Last known activity
May 1, 2020
Timeline
2010s
- Jan 1, 2011
Hospital Son Espases— Founded
Drugs by trial phase (20 distinct, 14 trials)
Phase 4 (5 own, 0 via acquisition)
Phase 3 (6 own, 0 via acquisition)
Phase 2 (9 own, 0 via acquisition)
Indications
Studied for
- Anemia
- Brain Edema
- Brain Injuries
- Brain Injuries, Traumatic
- Carcinoma
- Carcinoma, Renal Cell
- Chondrosarcoma
- Crohn Disease
- Edema
- Hypocalcemia
- Hypoparathyroidism
- Infections
- Inflammation
- Lung Diseases
- Lung Diseases, Obstructive
- Lung Neoplasms
- Lymphoma
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, Mantle-Cell
- Lymphoma, Non-Hodgkin
- Macular Degeneration
- Neoplasms, Fibrous Tissue
- Pseudomonas Infections
- Pulmonary Disease, Chronic Obstructive
- Solitary Fibrous Tumors
- Wet Macular Degeneration
Recent trials (19)
- NCT04303065Reponsible party - principal investigatorPhase 3May 1, 2020
- NCT04303065Lead sponsorPhase 3May 1, 2020
- NCT04012476Lead sponsorPhase 4Nov 30, 2016
- NCT02709720Overall official - principal investigatorPhase 2Apr 1, 2016
- NCT02876211Lead sponsorPhase 4Dec 1, 2014
- NCT02876211Reponsible party - principal investigatorPhase 4Dec 1, 2014
- NCT02066285Study directorPhase 2Jun 1, 2014
- NCT01986127Overall official - principal investigatorPhase 3Feb 1, 2014
- NCT01896284Overall official - principal investigatorPhase 4Jul 1, 2013
- NCT01577784Overall official - principal investigatorPhase 2Apr 1, 2012
- NCT01577368CollaboratorPhase 3May 1, 2011
- NCT01562977Overall official - principal investigatorPhase 2Apr 1, 2011
- NCT01599871Overall official - principal investigatorPhase 3Jan 1, 2011
- NCT01599871Lead sponsorPhase 3Jan 1, 2011
- NCT01599871Reponsible party - principal investigatorPhase 3Jan 1, 2011
Details
- Founded
- Palma de Mallorca, ES Jan 1, 2011
- Last known activity
- May 1, 2020